Aytu Bioscience vs Regenxbio Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Regenxbio Inc. is the larger company by market value: $513 M against $21 M for Aytu Bioscience, 25 times as much (market caps of Oct 26, 2026 for Aytu Bioscience and Oct 6, 2026 for Regenxbio Inc.).
- Regenxbio Inc. had more revenue: $170 M in the year to December 2025 against $58 M for Aytu Bioscience in the year to June 2026.
- Both made a net loss: $14 M for Aytu Bioscience and $194 M for Regenxbio Inc.
- Aytu Bioscience keeps more of each dollar of sales: a net margin of -24.8% against -113.8% for Regenxbio Inc.
- Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against -13.3% for Aytu Bioscience.
- Both are in the distress zone of the Altman Z-score.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Aytu Bioscience AYTU · #24,231 in the world | Regenxbio Inc. RGNX · #12,415 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $21 M | $513 M |
| Revenue | $58 M | $170 M |
| Net income | $-14 M▲ best | $-194 M |
| Employees | — | 372 |
| Valuation | ||
| Price to sales | 0.3× | 3.3× |
| Price to book | 0.6× | 5.0× |
| Free cash flow yield | 15.7%▲ best | -24.6% |
| Profitability | ||
| Gross margin | 64.0% | — |
| Operating margin | -14.4%▲ best | -94.6% |
| Net margin | -24.8%▲ best | -113.8% |
| Return on equity | -52.5%▲ best | -107.0% |
| Growth | ||
| Revenue growth | -13.3% | 104.5%▲ best |
| Revenue growth, 3 years a year | -18.8% | 14.8%▲ best |
| Financial strength | ||
| Debt to equity | 0.3× | — |
| Interest cover | -4.4× | — |
| Cash | ||
| Free cash flow margin | 5.7%▲ best | -74.1% |
| Strength scores | ||
| Piotroski F-score | 4 of 9 | — |
| Altman Z-score zone | distress | distress |
| Data as of | Market cap Oct 2026; ratios FY2026 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Aytu Bioscience or Regenxbio Inc.?
Regenxbio Inc. is the larger company by market value: $513 M against $21 M for Aytu Bioscience, 25 times as much (market caps of Oct 26, 2026 for Aytu Bioscience and Oct 6, 2026 for Regenxbio Inc.).
Which makes more money, Aytu Bioscience or Regenxbio Inc.?
Regenxbio Inc. had more revenue: $170 M in the year to December 2025 against $58 M for Aytu Bioscience in the year to June 2026. Both made a net loss: $14 M for Aytu Bioscience and $194 M for Regenxbio Inc.
Which is more profitable, Aytu Bioscience or Regenxbio Inc.?
Aytu Bioscience keeps more of each dollar of sales: a net margin of -24.8% against -113.8% for Regenxbio Inc.
Which is growing faster, Aytu Bioscience or Regenxbio Inc.?
Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against -13.3% for Aytu Bioscience.
Which is financially stronger, Aytu Bioscience or Regenxbio Inc.?
Both are in the distress zone of the Altman Z-score.